ldl

Documents about ldl

• Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)#1407427ClinicalTrials.gov
• The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion#411795HAL (France)
• AIDAVA G1 LDL-C Substudy Protocol#1295688ClinicalTrials.gov
• Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels#897557ClinicalTrials.gov
• Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol#805122ClinicalTrials.gov
• Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL)#918279ClinicalTrials.gov
• Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease#1137839ClinicalTrials.gov
• Evaluation of the Functionality of an Extract Rich in Phytosterols and Phytostanols on Parameters Related to the Lipid Profile of Individuals With Hypercholesterolemia, Mainly in the Levels of Total Cholesterol, LDL Cholesterol and Oxidized LDL#1140372ClinicalTrials.gov
• Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment#859734ClinicalTrials.gov
• The Effect of Meat and Food Drived Polyphenols on Oxidize LDL Level#826204ClinicalTrials.gov
• Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia#833259ClinicalTrials.gov
• A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet#834471ClinicalTrials.gov
• Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels#1085949ClinicalTrials.gov
• Effects of Atorvastatin Versus Probucol on Small Dense LDL#1086768ClinicalTrials.gov
• Effects of Chitin-Glucan on Oxidized Low-Density Lipoprotein (LDL)#1408054ClinicalTrials.gov
• DESIFOR-EXPAND (MHIF)#845676ClinicalTrials.gov
• Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers#880536ClinicalTrials.gov
• Oxidized LDL With Oxygen Therapy in Acute Coronary Syndrome.#1058481ClinicalTrials.gov
• Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)#1103079ClinicalTrials.gov
• A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia#1113083ClinicalTrials.gov
• Natural and Synthetic LDL-Based Imaging Probes for the Detection of Atherosclerotic Plaques#1251590IRIS
• Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study#883402ClinicalTrials.gov
• Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)#847977ClinicalTrials.gov
• Cheese Intake,CLA and Hypercholesterolemia#1384759ClinicalTrials.gov
• Effect of Diet Induced Ketosis on LDL Turnover Rates#1439613ClinicalTrials.gov
• Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI#994390ClinicalTrials.gov
• Gingival Crevicular Fluid Oxidized Low-Density Lipoprotein Levels in Health and Stage III/IV Periodontitis#1322765ClinicalTrials.gov
• Oat and Cholesterol#391020ClinicalTrials.gov
• Effect of a Black Garlic Extract on Cholesterol LDL Levels#878079ClinicalTrials.gov
• A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)#1292312ClinicalTrials.gov
• Estandarización de una metodología para determinar la incorporación de colesterol LDL en macrófagos diferenciados de monocitos aislados de sangre periférica.#1135592Repositorio
• Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction#1087291ClinicalTrials.gov
• Red-fleshed Apple as a Novel Anthocyanin-biofortified Food to Improve Cardiometabolic Risk Factors.#1113343ClinicalTrials.gov
• LDL cholesterol calculation methods and their influence on the indications for cholesterol-lowering treatment#137354HAL (France)
• Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C#804307ClinicalTrials.gov
• Optimal LDL-C Target in High-risk Patients After PCI#1280845ClinicalTrials.gov
• The Effect Of Low-Fat And Low-Cholesterol Dietary Intervention On LDL Sub-Groups In Turkısh Dyslipidemic Patients#968152ClinicalTrials.gov
• LDLR -3′UTR Deletions Identified as a Genetic Cause of Hypobetalipoproteinemia: Evidence From Familial and Population-Based Studies#1090665HAL (France)
• (H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol#1454827ClinicalTrials.gov
• Acute Microvascular Changes With LDL Apheresis#867282ClinicalTrials.gov
• Study of A3309 in Patients With Dyslipidemia#1161766ClinicalTrials.gov
• the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C#1381913ClinicalTrials.gov
• Phytosterol Supplementation and Cardiovascular Risk#903820ClinicalTrials.gov
• Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study#889688ClinicalTrials.gov
• Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia#899380ClinicalTrials.gov
• A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.#1451655ClinicalTrials.gov
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C Levels#1486269ClinicalTrials.gov
• Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C#1074376ClinicalTrials.gov
• Evaluation of Crestor® (Rosuvastatin) in Daily Practice#1339962ClinicalTrials.gov
• EARLY: Educational Intervention to Improve Patient Awareness on Early LDL-C Lowering in Secondary Prevention#859149ClinicalTrials.gov